Related Experiment Video
Updated: Jun 12, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research
Anthony J Tyndall1, Bettina Bannert, Madelon Vonk
1Department of Rheumatology, University of Basel, Basel, Switzerland.
Annals of the Rheumatic Diseases
|June 17, 2010
Summary
Systemic sclerosis (SSc) mortality is primarily driven by disease-related complications like pulmonary fibrosis and pulmonary arterial hypertension (PAH). Identifying risk factors such as proteinuria and cardiac issues is crucial for managing SSc patient survival.
Area of Science:
- Rheumatology
- Pulmonology
- Cardiology
- Epidemiology
Background:
- Systemic sclerosis (SSc) is a complex autoimmune disease with significant mortality.
- Understanding the causes and predictors of death in SSc is essential for improving patient outcomes.
Purpose of the Study:
- To investigate the primary causes of mortality in a large cohort of patients with systemic sclerosis.
- To identify independent predictors of mortality in systemic sclerosis.
Main Methods:
- Analysis of 5860 patients from the EULAR Scleroderma Trials and Research (EUSTAR) cohort.
- Utilized Kaplan-Meier and Cox proportional hazards models to assess survival and identify mortality predictors.
- Collected data on causes of death and comorbidities through structured questionnaires.
Main Results:
- Pulmonary fibrosis, pulmonary arterial hypertension (PAH), and cardiac causes were the leading SSc-related causes of death.
- Infections and malignancies were major non-SSc causes of mortality.
- Independent mortality predictors included proteinuria, PAH, pulmonary restriction, dyspnea severity, reduced diffusing capacity, age at Raynaud's onset, and modified Rodnan skin score.
Conclusions:
- Disease-related complications, particularly pulmonary fibrosis, PAH, and cardiac issues, are the predominant causes of death in SSc.
- Several clinical factors independently predict mortality in SSc patients.
- These findings highlight the importance of monitoring specific organ systems and risk factors in SSc management.
Related Concept Videos
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...